Dr. Lal PathLabs Limited (BOM:539524)
India · Delayed Price · Currency is INR 1,945.45
-15.50 (-0.79%)
At close: Oct 7, 2026
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 325.55 billion as of October 7, 2026. Its market cap has increased by 22.54% in one year.
Market Cap
325.55B
Enterprise Value
314.56B
Revenue
28.91B
Global Rank
n/a
Country Rank
n/a
PE Ratio
60.56
ChartMarket Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 325.55B, an increase of 377.47%. That is a compound annual growth rate of 15.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 325.55B | 31.40% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.33T |
| Divi's Laboratories | 2.44T |
| Lenskart Solutions | 1.20T |
| Zydus Lifesciences | 1.16T |
| Emcure Pharmaceuticals | 364.64B |
| Wockhardt | 353.65B |
| Narayana Hrudayalaya | 350.10B |
| Global Health | 349.75B |